Background: The validity and reproducibility of the 6-minute stepper test (6MST) have already been demonstrated in patients with chronic obstructive pulmonary disease (COPD). Objectives: The aim of this study was to evaluate the responsiveness of the 6MST to pulmonary rehabilitation (PR) in patients with COPD, to determine a minimal important difference (MID) for the 6MST, and to compare the 6MST and the 6-minute walk test (6MWT). Methods: Sixty-two patients with COPD were included in a prospective experimental study. Participants underwent a 3-week inpatient PR program. The primary outcome was the change in the number of steps during the 6MST measured before and after PR. The secondary outcome included the change in the 6-minute walking distance (6MWD) pulse oximetry, heart rate, dyspnea, and leg discomfort during the tests measured before and after PR. MID was determined by anchor-based and distribution approaches. Results: After PR, we observed a significant increase in the number of steps during the 6MST (22.5 steps; 95% CI 13.8-31.3; p < 0.0001) and in the 6MWD (26.6 m; 95% CI 17.6-35.5; p < 0.0001). The 6MST and 6MWT were improved by 10.1 and 6.5%, respectively. The number of steps during the 6MST was significantly correlated with the 6MWD before (r = 0.72; p < 0.0001) and after PR (r = 0.66; p < 0.0001). MID was estimated to be around 20 steps. Conclusion: The 6MST appears to be as responsive as the 6MWT in assessing functional improvement during PR in patients with COPD. The 6MST is a low-cost assessment and requires limited space.

Keywords:
Chronic obstructive pulmonary disease, Field test, Evaluation, Exercise capacity, Minimal important difference, 6-minute stepper test, Pulmonary rehabilitation
1.
Spruit MA, Pitta F, Garvey C, ZuWallack RL, Roberts CM, Collins EG, Goldstein R, McNamara R, Surpas P, Atsuyoshi K, López-Campos J-L, Vogiatzis I, Williams JEA, Lareau S, Brooks D, Troosters T, Singh SJ, Hartl S, Clini EM, Wouters EFM: Differences in content and organisational aspects of pulmonary rehabilitation programmes. Eur Respir J 2014;43:1326-1337.
2.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories: ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117.
3.
Polkey MI, Spruit M, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PM, Tal-Singer R, Agustí A, Bakke PS, Coxson HO, Lomas D, Macnee W, Rennard S, Silverman EK, Miller BE, Crim C, Yates J, Wouters EFM, Celli B: Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med 2013;187:382-386.
4.
Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-1012.
5.
Borel B, Provencher S, Saey D, Maltais F: Responsiveness of various exercise-testing protocols to therapeutic interventions in COPD. Pulm Med 2013;2013:410748.
6.
Annegarn J, Meijer K, Passos VL, Stute K, Wiechert J, Savelberg HH, Schols AMWJ, Wouters EF, Spruit MA; Ciro+ Rehabilitation Network: Problematic activities of daily life are weakly associated with clinical characteristics in COPD. J Am Med Dir Assoc 2012;13:284-290.
7.
Borel B, Fabre C, Saison S, Bart F, Grosbois J: An original field evaluation test for chronic obstructive pulmonary disease population: the six-minute stepper test. Clin Rehabil 2010;24:82-93.
8.
Rodriguez-Roisin R, Anzueto A, Bourbeau J: The global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010. http://www.goldcopd.org/.
9.
Holland AE, Spruit M, Troosters T, Puhan M, Pepin V, Saey D, McCormack MC, Carlin BW, Sciurba FC, Pitta F, Wanger J, MacIntyre N, Kaminsky D, Culver BH, Revill SM, Hernandes N, Andrianopoulos V, Camillo CA, Mitchell KE, Lee AL, Hill CJ, Singh SJ: An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014;44:1428-1446.
10.
Gosselink R, De Vos J, van den Heuvel SP, Segers J, Decramer M, Kwakkel G: Impact of inspiratory muscle training in patients with COPD : what is the evidence? Eur Respir J 2011;37:416-425.
11.
Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
12.
Revicki D, Hays RD, Cella D, Sloan J: Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008;61:102-109.
13.
Jones PW: Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002;19:398-404.
14.
Grosbois JM, Le Rouzic O, Monge E, Bart F, Wallaert B: Comparison of home-based and outpatient, hospital-based, pulmonary rehabilitation in patients with chronic respiratory diseases (in French). Rev Pneumol Clin 2013;69:10-17.
15.
Coquart JB, Lemaître F, Castres I, Saison S, Bart F, Grosbois JM: Reproducibility and sensitivity of the 6-minute stepper test in patients with COPD. COPD 2015;12:533-538.
16.
Rammaert B, Leroy S, Cavestri B, Wallaert B, Grosbois JM: Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis (in French). Rev Mal Respir 2009;26:275-282.
17.
Ries AL: Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD 2005;2:105-110.
18.
Diaz O, Morales A, Osses R, Klaassen J, Lisboa C, Saldias F: Six-minute walk test and maximum exercise test in cycloergometer in chronic obstructive pulmonary disease. Are the physiological demands equivalent? (in Spanish). Arch Bronconeumol 2010;46:294-301.
19.
Poulain M, Durand F, Palomba B, Ceugniet F, Desplan J, Varray A, Préfaut C: 6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest 2003;123:1401-1407.
20.
Turner SE, Eastwood PR, Cecins NM, Hillman DR, Jenkins SC: Physiologic responses to incremental and self-paced exercise in COPD: a comparison of three tests. Chest 2004;126:766-773.
21.
Delourme J, Stervinou-Wemeau L, Salleron J, Grosbois JM, Wallaert B: Six-minute stepper test to assess effort intolerance in interstitial lung diseases. Sarcoidosis Vasc Diffuse Lung Dis 2012;29:107-112.
22.
Puhan MA, Mador MJ, Held U, Goldstein R, Guyatt GH, Schünemann HJ: Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J 2008;32:637-643.
23.
Puhan MA, Chandra D, Mosenifar Z, Ries A, Make B, Hansel NN, Wise RA, Sciurba F: The minimal important difference of exercise tests in severe COPD. Eur Respir J 2011;37:784-790.
24.
de Torres JP, Pinto-Plata V, Ingenito E, Bagley P, Gray A, Berger R, Celli B: Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest 2002;121:1092-1098.
25.
Spruit M, Singh SJ, Garvey C, Zu Wallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WDC, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FME, Casaburi R, Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, Van Der Palen J, Troosters T, Janssen DJ, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, et al: An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188:e13-e64.
26.
Singh SJ, Puhan M, Andrianopoulos V, Hernandes N, Mitchell KE, Hill CJ, Lee AL, Camillo CA, Troosters T, Spruit M, Carlin BW, Wanger J, Pepin V, Saey D, Pitta F, Kaminsky D, McCormack MC, MacIntyre N, Culver BH, Sciurba FC, Revill SM, Delafosse V, Holland AE: An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J 2014;44:1447-1478.
27.
Beaumont M, Reychler G, Le Ber-Moy C, Peran L: The effects of a pulmonary rehabilitation program in relation to the severity of COPD (in French). Rev Mal Respir 2011;28:297-305.
28.
Péran L, Lochon C, Beaumont M, Pichon R: Effet d'un programme de réhabilitation respiratoire sur la distension dynamique selon la sévérité de la BPCO d'après l'index BODE. Rev Kinesither 2012;12:49-56.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.